Product Name | MF | CAS | Details |
---|
H-ITVVDALHEIPVK^-OH | Details |
Myr-FTEIPTI^-OH | Details |
Azidocyclopentane | C5H9N3 | 33670-50-7 | Details |
1-[(Trimethylsilyl)oxy]cyclopentane-1-carbonitrile | C9H17NOSi | 25438-35-1 | Details |
2-(4-Methyl-piperazine-1-sulfonyl)-phenylamine | C11H17N3O2S | 436095-29-3 | Details |
2-Propyloxan-4-one | C8H14O2 | 13519-42-1 | Details |
C1QB antibody | Details |
Decursinol | C14H14O4 | 23458-02-8 | Details |
4-Chloro-5,6,7,8-tetrahydroquinazoline | C8H9ClN2 | 1125-62-8 | Details |
Malate dehydrogenase,buffered aqueous glycerol solution, 600-1000 units/mg protein (biuret) | NULL | 9001-64-3 | Details |
2-Cyanopyrazine | C5H3N3 | 19847-12-2 | Details |
Ac-Asp-Glu ? H2O | C11H16N2O8 | 3106-85-2 | Details |
(4-Hydroxy-1,1-dioxo-tetrahydro-1lambda*6*-thiophen-3-ylamino)-acetic acid | C6H11NO5S | 294669-00-4 | Details |
2'-Deoxy-N2-isobutyrylguanosine | C14H19N5O5 | 68892-42-2 | Details |
Methyl 2-cyclohexyl-2-hydroxyphenylacetate | C15H20O3 | 10399-13-0 | Details |
2-(5-Methyl-1,2-oxazol-3-yl)ethan-1-amine hydrochloride | C6H11ClN2O | 1797983-79-9 | Details |
(3R)-3-{[(tert-Butoxy)carbonyl](methyl)amino}butanoic acid | C10H19NO4 | 914461-60-2 | Details |
N-(Piperidin-3-yl)naphthalene-2-carboxamide hydrochloride | C16H19ClN2O | 1384431-17-7 | Details |
MCP2 protein | Details |
anti-Cat SAA Antibody Monoclonal | Details |
rac trans-3-amino-1-oxyl-2,2,5,5-tetramethylpyrrolidine-4-carboxylic acid | C9H18N2O3 | 15871-58-6 | Details |
4-Methoxyphenyl 2,3,6-tri-O-benzyl-4-O-(2,3-di-O-benzyl-b-D-galactopyranosyl)-b-D-glucopyranoside | C54H58O12 | Details |
2-Chloro-2-phenyl-N-(propan-2-yl)acetamide | C11H14ClNO | 184590-56-5 | Details |
Atrial Natriuretic Peptide (1-28), rat | C128H205N45O39S2 | 88898-17-3 | Details |
N-Cyclopropyl-2-hydroxy-2-(piperidin-4-yl)acetamide, trifluoroacetic acid | C12H19F3N2O4 | 1803611-53-1 | Details |
5-(Methylamino)nicotinic acid | C7H8N2O2 | 91702-88-4 | Details |
H-LGGPEAGLGEYLFER-OH | Details |
3-(Trimethylsilyl)-2-propynal | C6H10OSi | 2975-46-4 | Details |
1,4-Difluoro-2-(S-methylsulfonimidoyl)benzene | C7H7F2NOS | 2059934-12-0 | Details |
3-Azido-5-(trifluoromethyl)pyridine-2-carbonitrile | C7H2F3N5 | 338420-29-4 | Details |
2',3'-Anhydroinosine | C10H10N4O4 | 31766-13-9 | Details |
Oritavancin diphosphate | C86H103Cl3N10O34P2 | 192564-14-0 | Details |
rac-(3R,4S)-4-Amino-3,4-dihydro-2H-1-benzopyran-3-ol | C9H11NO2 | 58810-68-7 | Details |
4-(2-(tert-Butyl)-5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1H-imidazol-4-yl)pyridine | C20H21N3O2 | 1859918-13-0 | Details |
N,N-Dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide | C8H10N2O2 | 412032-33-8 | Details |
Mouse anti Rat IgG1 | Details |
Clusterin-Like 1 Blocking Peptide | Details |
4,4-Piperidinedimethanol | C7H15NO2 | 848070-24-6 | Details |
2-(4H-1,2,4-Triazol-3-yl)propan-2-amine dihydrochloride | C5H11ClN4 | 1384427-85-3 | Details |
Retinylaldehyde | C20H28O | 116-31-4 | Details |
2-Methyl-5-nitroimidazole-1-propanol | C7H11N3O3 | 1077-93-6 | Details |
N-(4-Aminophenyl)-2-(dimethylamino)acetamide | C10H15N3O | 25786-09-8 | Details |
3-Bromo-5-methoxypyridin-4-amine | C6H7BrN2O | 1417618-49-5 | Details |
Ac-WLA-AMC | C32H37N5O6 | Details |
[3-(3,3-Dimethylbutoxy)pyridin-4-yl]methanamine | C12H20N2O | 1515070-45-7 | Details |
3-Bromo-5-(4-methoxyphenyl)-1,2,4-oxadiazole | C9H7BrN2O2 | 1566194-77-1 | Details |
Miransertib (ARQ 092) HCl | C27H25ClN6 | 1313883-00-9 | Details |
3-(Chloromethyl)aniline hydrochloride | C7H9Cl2N | 145883-50-7 | Details |
TRAF6 Peptide trifluoroacetate salt | C145H238N34O44 | 852805-92-6 | Details |
CSRP3 antibody | Details |
{1,7-Dioxaspiro[4.5]decan-2-yl}methanamine | C9H17NO2 | 1870529-68-2 | Details |
2-Azidoethyl b-D-fructopyranoside | C8H15N3O6 | 99042-58-7 | Details |
SOCS7 antibody | Details |
1-Bromo-3-(isopropanesulfonyl)benzene | C9H11BrO2S | 70399-01-8 | Details |
tert-butyl N-[1-(aminomethyl)cyclobutyl]carbamate | C10H20N2O2 | 1286330-22-0 | Details |
H-SSEDPNEDIVER^-OH | Details |
Dnp-pyaywmr trifluoroacetate | C54H65N13O14S | 135662-06-5 | Details |
[(2R)-2-Aminopropyl](methyl)(propan-2-yl)amine | C7H18N2 | 1418293-58-9 | Details |
5-Phenylthieno[2,3-d]pyrimidin-4-amine | C12H9N3S | 195193-10-3 | Details |
5-(Chloromethyl)-4-iodo-1-methyl-1H-pyrazole hydrochloride | C5H7Cl2IN2 | 2059950-26-2 | Details |
2-(1,4,7,10-Tetraazacyclododecan-1-yl)acetic acid trihydrochloride | 2137629-28-6 | Details |
methyl 4-(phenylamino)-1-(2-acetoxybenzoate)thiosemicarbazide | C17H17N3O4S | 1022580-81-9 | Details |
PERLD1 antibody | Details |
CGA Antibody | Details |
N-[1-Chloro-3-(hydroxyimino)butan-2-ylidene]hydroxylamine | C4H7ClN2O2 | 82506-99-8 | Details |
(5-Fluoro-2,2-dimethyl-1,3-dioxan-5-yl)methanol | C7H13FO3 | 133384-80-2 | Details |
LETMD1 antibody | Details |
9-Azaspiro[5.6]dodecane | C11H21N | 51991-09-4 | Details |
H-KLVVVGADGV^-OH | Details |
3-(2,5-Dihydro-1H-pyrrol-1-yl)propan-1-amine | C7H14N2 | 37632-58-9 | Details |
[6-(2,2,2-Trifluoroethoxy)pyridin-3-yl]methanamine | C8H9F3N2O | 771584-26-0 | Details |
4-Amino-4-methyl-cyclohexanol hydrochloride | C7H16ClNO | 1965309-32-3 | Details |
H-FEVQVTVPK^-OH | Details |
NTF5 Blocking Peptide | Details |
6-Chloro-1-isopropyl-1h-pyrazolo[3,4-b]pyridine-5-carbaldehyde | C10H10ClN3O | 885461-63-2 | Details |
3-(Piperidin-1-yl)propanimidamide dihydrochloride | C8H18ClN3 | 1423033-77-5 | Details |
2-Methoxy-5-(1,3-thiazolidin-2-yl)phenol | 156781-04-3 | Details |
Helvolic acid | C33H44O8 | 29400-42-8 | Details |
7-(Benzyloxy)-1,2,3,4-tetrahydroisoquinoline | C16H17NO | 152035-13-7 | Details |
5-Methyl-4-(3-methylphenyl)-4H-1,2,4-triazole-3-thiol | C10H11N3S | 592537-77-4 | Details |
tert-Butyl 3-amino-1H-pyrazole-4-carboxylate | C8H13N3O2 | 1646543-44-3 | Details |
2-Methyl-octahydro-1H-isoindol-4-ol hydrochloride | C9H18ClNO | 2193065-34-6 | Details |
2-(2,3,6-Triazino[5,4-β]indol-3-ylthio)propanoic acid | C12H10N4O2S | 333787-61-4 | Details |
3-(Methylamino)azetidine-3-carboxamide hydrochloride | C5H12ClN3O | 736994-10-8 | Details |
2-Amino-2-(4-hydroxyphenyl)propanoic acid hydrochloride | C9H12ClNO3 | 871842-95-4 | Details |
5-Bromo-2-cyclobutyl-1,3-oxazole | C7H8BrNO | 1391737-95-3 | Details |
{1-[(Oxolan-3-yl)methyl]-1H-imidazol-2-yl}methanol | C9H14N2O2 | 1936588-39-4 | Details |
2-Chloro-N-ethylaniline hydrochloride | C8H11Cl2N | 860736-20-5 | Details |
JMJD6 Blocking Peptide | Details |
CD45R antibody (Azide Free) | Details |
PF-06751979 | C18H19F2N5O3S2 | 1818339-66-0 | Details |
RPA2 antibody (HRP) | Details |
5H,6H,7H,8H-Imidazo[1,2-a]pyridine-8-carboxylic acid | C8H10N2O2 | 1235440-64-8 | Details |
5-Oxo-octahydroindolizine-8a-carboxylic acid | C9H13NO3 | 2092066-24-3 | Details |
(1-Cyanocyclopentyl)methanesulfonamide | C7H12N2O2S | 1443981-15-4 | Details |
1-(1H-Indol-3-yl)propan-2-ol | C11H13NO | 3364-35-0 | Details |
methyl 3-(((4-(2-fluorophenyl)piperazinylthioxomethyl)amino)thiophene-2-carboxylate | C17H18FN3O2S2 | 892272-82-1 | Details |
2-(3,3-Dimethoxycyclobutyl)ethan-1-amine | C8H17NO2 | 2098106-68-2 | Details |
5-Amino-6-methoxypyridine-2-carbonitrile | C7H7N3O | 1314922-96-7 | Details |
Methyl 6-oxospiro[3.3]heptane-2-carboxylate | C9H12O3 | 1138480-98-4 | Details |
Product Total: Product Page: | ||||
427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 |